Compare OCS & INOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OCS | INOD |
|---|---|---|
| Founded | 2003 | 1988 |
| Country | Switzerland | United States |
| Employees | 3 | 3000 |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | N/A | 1996 |
| Metric | OCS | INOD |
|---|---|---|
| Price | $31.28 | $89.35 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $42.00 | ★ $100.00 |
| AVG Volume (30 Days) | 432.7K | ★ 2.3M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.37 |
| EPS | N/A | ★ 0.42 |
| Revenue | N/A | ★ $86,775,000.00 |
| Revenue This Year | $466.06 | $38.42 |
| Revenue Next Year | $479.73 | $27.03 |
| P/E Ratio | ★ N/A | $218.44 |
| Revenue Growth | N/A | ★ 9.84 |
| 52 Week Low | $16.00 | $33.47 |
| 52 Week High | $34.48 | $114.77 |
| Indicator | OCS | INOD |
|---|---|---|
| Relative Strength Index (RSI) | 62.68 | 73.80 |
| Support Level | $19.05 | $39.15 |
| Resistance Level | N/A | $93.82 |
| Average True Range (ATR) | 1.49 | 7.72 |
| MACD | 0.41 | 5.84 |
| Stochastic Oscillator | 62.93 | 66.30 |
Oculis Holding AG is a biopharmaceutical company purposefully driven to save sight and improve eye care. It includes OCS-01, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED); and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company has locations in five countries: Switzerland, Iceland, France, U.S. and Hong Kong.
Innodata Inc is a data engineering company. It is helping companies deploy and integrate AI into their operations and products and providing AI-enabled industry platforms. The Company's operations are classified in three reporting segments: Digital Data Solutions (DDS), Synodex and Agility. Key revenue is generated from DDS segment provides AI data preparation services, collecting or creating training data, annotating training data, and training AI algorithms for its customers, and AI model deployment and integration. It also provides a range of data engineering support services including data transformation, data curation, data hygiene, data consolidation, data extraction, data compliance, and master data management.